Sweet syndrome induced by FLT3 inhibitors: case report and literature review
ABSTRACTBackground: Acute febrile neutrophilic dermatosis, also commonly referred to as Sweet syndrome, is often associated with tumors, infections, immune disorders and medications. FLT3 inhibitor-induced Sweet syndrome is a rare complication.Methods and results: We report a patient with relapsed a...
Main Authors: | Linhui Yang, Ran Zhang, Hongbing Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Hematology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2337230 |
Similar Items
-
Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
by: Moo-Kon Song, et al.
Published: (2022-10-01) -
“FLipping” the Story: FLT3-Mutated Acute Myeloid Leukemia and the Evolving Role of FLT3 Inhibitors
by: Tristan E. Knight, et al.
Published: (2022-07-01) -
Mechanisms Underlying Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
by: Motoki Eguchi, et al.
Published: (2020-07-01) -
Ulcerative Colitis Concomitant with Cytomegalovirus Infection, Bullous Sweet’s Syndrome, and Acute Myeloid Leukemia: A Case Report and Literature Review
by: Zhu F, et al.
Published: (2023-08-01) -
Unique challenges to diagnosing sweet syndrome following induction chemotherapy for relapsed Acute Myeloid Leukemia (AML): A case and brief-review
by: Samvel Nazaretyan, et al.
Published: (2023-01-01)